Investor's Business Daily on MSN
Edwards, the 'cleanest large-cap medtech story,' launches on second-quarter beat
Edwards Lifesciences stock fell Friday, though the medtech company beat Wall Street's top- and bottom-line expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results